May 28, 2015
1 min read
Save

ACR praises Rep. Diane Black, ICD-TEN Act to transition from ICD-9 to ICD-10 coding system

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The American College of Rheumatology praised U.S. Representative Diane Black, R-Tenn., for introducing the ICD-TEN Act that, if passed, would institute an 18-month “safe harbor” period after the Oct. 1, 2015, deadline to transition from the use of ICD-9 codes to ICD-10 codes.

The intention of the bill is to help physicians, administrative staff and medical records management professionals adapt to the changes in coding of patient records, according to a press release from the American College of Rheumatology (ACR).

“As with any major technological overhaul, the transition to ICD-10 will not come without challenges. Providers across the U.S. deserve assurance from CMS that the system is fully functioning,” William Harvey, MD, MSc, FACR, a practicing rheumatologist and chair of the ACR Government Affairs Committee, said in the release. “This assurance, along with an 18-month transition period that allows physicians and IT professionals to adjust to any initial ‘kinks’ in the system - without the threat of nonpayment looming overhead - will allow both providers and CMS to move forward with ICD-10 in a responsible way.”

Black introduced the bill, H.R. 2247, on May 12. The bill requires the CMS to conduct complete, end-to-end testing of the system prior to implementation and to certify to Congress that the Medicare fee-for-service claims processing system is fully functioning after transitioning to the ICD-10 standard.

“I believe transitioning to ICD-10 is needed and will help improve health care delivery in the long run, but we must ensure the transition is as smooth as possible,” Black said. “An 18-month transition period allows us to innovate without putting our nation’s most vulnerable providers, and the patients who rely on their services, at risk.”

Reference: www.rheumatology.org.